Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
Author:
Affiliation:
1. Infection, Inflammation and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London, UK
2. Arthritis Research UK Centre for Adolescent Rheumatology, London, UK
Funder
Arthritis research UK
Rosetrees Trust
Arthritis Research UK
Great Ormond Street Hospital Children’s Charity
Great Ormond Street Hospital NHS Foundation Trust
NIHR Great Ormond Street Hospital Biomedical Research Centre
NHS
NIHR
Publisher
Oxford University Press (OUP)
Subject
Clinical Neurology
Link
http://academic.oup.com/brain/article-pdf/142/3/e8/29005571/awz005.pdf
Reference9 articles.
1. Type I interferon pathway in adult and juvenile dermatomyositis;Baechler;Arthritis Res Ther,2011
2. Comparison of the utility and validity of three scoring tools to measure skin involvement in patients with juvenile dermatomyositis;Campanilho-Marques;Arthritis Care Res (Hoboken),2016
3. Endothelial injury and repair in systemic vasculitis of the young;Clarke;Arthritis Rheum,2010
4. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis;Ladislau;Brain,2018
5. Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis;Omoyinmi;PLoS One,2017
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review;Children;2024-08-27
2. Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons;Expert Opinion on Pharmacotherapy;2024-08-12
3. Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis;Rheumatology;2024-07-29
4. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study;Journal of Autoimmunity;2024-07
5. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature;Seminars in Arthritis and Rheumatism;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3